200 related articles for article (PubMed ID: 19002021)
1. Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes.
Chifenti B; Morelli M; Zavaglia M; Coviello DA; Guerneri S; Santucci A; Paffetti A; Masetti M; Locci MT; Bertacca G; Capodanno A; Collecchi P; Campani D; Mosca F; Bevilacqua G; Cavazzana AO
Pancreas; 2009 Mar; 38(2):184-96. PubMed ID: 19002021
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of four human pancreatic carcinoma cell lines. Genetic alterations in the TGFBR2 gene but not in the MADH4 gene.
Ku JL; Yoon KA; Kim WH; Jang Y; Suh KS; Kim SW; Park YH; Park JG
Cell Tissue Res; 2002 May; 308(2):205-14. PubMed ID: 12037578
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
4. Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background.
Eisold S; Ryschich E; Linnebacher M; Giese T; Nauheimer D; Wild A; Bartsch DK; Büchler MW; Schmidt J
Cancer; 2004 May; 100(9):1978-86. PubMed ID: 15112280
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
[TBL] [Abstract][Full Text] [Related]
6. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
[TBL] [Abstract][Full Text] [Related]
8. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
9. Five primary human pancreatic adenocarcinoma cell lines established by the outgrowth method.
Rückert F; Aust D; Böhme I; Werner K; Brandt A; Diamandis EP; Krautz C; Hering S; Saeger HD; Grützmann R; Pilarsky C
J Surg Res; 2012 Jan; 172(1):29-39. PubMed ID: 21683373
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
Hoorens A; Prenzel K; Lemoine NR; Klöppel G
J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
12. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of human pancreatic adenocarcinoma cell line in tissue culture and the nude mouse.
Kong D; Nishino N; Shibusawa M; Kusano M
Tissue Cell; 2007 Aug; 39(4):217-23. PubMed ID: 17560620
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma.
Cui Y; Li T; Zhang D; Han J
Cancer Invest; 2010 Mar; 28(3):242-7. PubMed ID: 20158339
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
Griffin CA; Morsberger L; Hawkins AL; Haddadin M; Patel A; Ried T; Schrock E; Perlman EJ; Jaffee E
Cytogenet Genome Res; 2007; 118(2-4):148-56. PubMed ID: 18000365
[TBL] [Abstract][Full Text] [Related]
16. [General rules for the study of pancreatic cancer by molecular biological aspect].
Omata M; Tada M
Nihon Geka Gakkai Zasshi; 2000 Feb; 101(2):233-6. PubMed ID: 10734643
[TBL] [Abstract][Full Text] [Related]
17. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell.
Li Y; Qian H; Li X; Wang H; Yu J; Liu Y; Zhang X; Liang X; Fu M; Zhan Q; Lin C
J Gene Med; 2009 Jan; 11(1):3-13. PubMed ID: 19003803
[TBL] [Abstract][Full Text] [Related]
19. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S
Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of a human pancreatic adenocarcinoma cell line(JF305) with p53 expression].
Li X; Wang H; Jiang Y
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):181-3. PubMed ID: 7956694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
